Belite Bio (BLTE) Non Operating Income (2022 - 2026)

Belite Bio's Non Operating Income history runs 5 years deep, the most recent figure standing at $5.7 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 363.39% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.4 billion (up 57.9% YoY), while the FY2025 annual figure was $6.6 million, up 71.0% from the prior year.
• Non Operating Income was $5.7 million for Q1 2026 at Belite Bio, down from $2.8 billion in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $2.8 billion in Q4 2025 to a low of -$8.0 million in Q1 2023.
• Historically, Non Operating Income has averaged $595.5 million across 5 years, with a median of $126.0 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Non Operating Income plunged 99.98% in 2023, then jumped 3929529.63% in 2024.
• A 5-year view of Non Operating Income shows it stood at -$62000.0 in 2022, then surged by 41.94% to -$36000.0 in 2023, then jumped by 3769544.44% to $1.4 billion in 2024, then soared by 102.87% to $2.8 billion in 2025, then slumped by 99.79% to $5.7 million in 2026.
• The last three Non Operating Income figures came in at $5.7 million (Q1 2026), $2.8 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.